Results 151 to 160 of about 3,098,056 (351)

The Health Interview [PDF]

open access: bronze, 1965
Mildred I. Walker
openalex   +1 more source

Capturing what matters: Patient‐reported LGI1‐ANTibody encephalitis outcome RatiNg scale (LANTERN)

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Abstract Background LGI1‐antibody encephalitis (LGI1‐Ab‐E) is a common form of autoimmune encephalitis where most patients demonstrate ‘good’ clinician‐rated outcomes. However, more targeted questionnaires reveal numerous debilitating symptoms for many years.
Mark J Kelly   +9 more
wiley   +1 more source

Political Priorities and Political Campaigns in Higher Education. Interview with Professor Ulrich Teichler

open access: yesВопросы образования, 2015
The editors of the Voprosy obrazovaniya have interviewed Ulrich Teichler, professor at the International Center for Higher Education Research Kassel, participant in the Conference of Higher Education Researchers held in October 2014 in Moscow.
Ulrich Teichler
doaj  

An interview with [PDF]

open access: yesDental Press Journal of Orthodontics, 2017
openaire   +3 more sources

The mini international neuropsychiatric interview

open access: yesEuropean psychiatry, 1998
Y. Lecrubier   +3 more
semanticscholar   +1 more source

Amygdala Neurodegeneration: A Key Driver of Visual Dysfunction in Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Visual disability in Parkinson's disease (PD) is not fully explained by retinal neurodegeneration. We aimed to delineate the brain substrate of visual dysfunction in PD and its association with retinal thickness. Methods Forty‐two PD patients and 29 controls underwent 3‐Tesla MRI, retinal spectral‐domain optical coherence tomography,
Asier Erramuzpe   +15 more
wiley   +1 more source

Interview with Volker Strehl [PDF]

open access: yesEnumerative Combinatorics and Applications, 2021
ECA Interviews
doaj  

Associations of Cerebrospinal Fluid Orexin‐A, Alzheimer Disease Biomarkers, and Cognitive Performance

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACTObjectiveCerebrospinal fluid (CSF) orexin‐A has been suggested to be a biomarker of Alzheimer disease (AD). In both cognitively unimpaired healthy older adults and individuals with symptomatic AD, CSF orexin‐A is positively associated with CSF Aβ42, p‐tau181, and total tau (t‐tau) concentrations.
Ruijin Lu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy